BFM Podcast
Innoquest Pathology-Rebranding and Dual Accreditation
26-Sep-22 09:15
Dr Nelson Nheu, CEO, Innoquest Pathology Sdn Bhd
Earlier this year, Gribbles Pathology, a leading clinical lab testing service provider in Malaysia, undertook a rebranding exercise into Innoquest Pathology. We speak to Dr Nelson Nheu, CEO of Innoquest Pathology, on what this means for doctors and patients, and Gribbles' network of diagnostic labs. For our full range of accredited services, contact us today at: https://www.innoquest.com.my/contact/
More articles on BFM Podcast
A Future-Ready Medical Program at Sir Jeffrey Cheah Sunway Medical School
Created by Tan KW | Nov 21, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
2
3
Koon Yew Yin's Blog
4
save malaysia!
6
7
THE INVESTMENT APPROACH OF CALVIN TAN
8
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
MQ Trading Signals
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
